The study obtained the results of treatment the patients with non-small cell lung carcinoma for two large periods: before the acceptance of common standards in the treatment of cancer patients, from 1995 to 2000 years and after the introduction and acceptance of several revisions of algorithms of diagnosis and treatment of patients with malignant neoplasms from 2012 to 2018 years. As a result of the analysis, it was found that the use of algorithms contributed to an increase of the overall 5-year survival rate of patients with non-small cell lung cancer by 23.5%.